Telangana's drug control wing put out a public advisory telling people not to buy or self-inject experimental peptides from unregulated sellers.
Recap by typeshit. Post by TG SAFE - Drug Wing on X.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Pipes argues some of these injectables are still in clinical trials yet already reach American buyers, and wants the FDA to target suppliers at the source.
Technology Networks reports that people with the fatty liver disease MASLD who took GLP-1 drugs had lower mortality and fewer hospital stays.
Loading…